A.P. Pharma, Inc. (NASDAQ:APPA)
CAPS Rating:
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked APPA yet. Tell us why you think APPA will outperform or underperform the market.
RSS Headlines
Fool UK
